TrialAntimicrobial agents and chemotherapy2017

Safety, Pharmacokinetics, and Antiviral Activity of a Novel HIV Antiviral, ABX464, in Treatment-Naive HIV-Infected Subjects in a Phase 2 Randomized, Controlled Study.

Jean-Marc Steens et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.